{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:27:08Z","timestamp":1793600828033,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ygyno.2026.03.012","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T17:48:21Z","timestamp":1775497701000},"page":"85-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Evaluating alternative protocols for preventing cisplatin-induced acute kidney injury during hyperthermic intraperitoneal chemotherapy in ovarian cancer"],"prefix":"10.1016","volume":"208","author":[{"given":"Jimin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keunyeok","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeeyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Hyuk","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Wook","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk-Joon","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2026.03.012_bb0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cncr.23553","article-title":"Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer","volume":"113","author":"Di Giorgio","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2026.03.012_bb0010","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamasurg.2023.3944","article-title":"Hyperthermic intraperitoneal chemotherapy after interval cytoreductive surgery for patients with advanced-stage ovarian cancer who had received neoadjuvant chemotherapy","volume":"158","author":"Lee","year":"2023","journal-title":"JAMA Surg."},{"key":"10.1016\/j.ygyno.2026.03.012_bb0015","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2026.03.012_bb0020","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00204-012-0821-7","article-title":"Cisplatin-induced nephrotoxicity and targets of nephroprotection: An update","volume":"86","author":"dos Santos","year":"2012","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ygyno.2026.03.012_bb0025","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/ijgc-2018-000099","article-title":"Predictive risk factors of acute kidney injury after cytoreductive surgery and cisplatin-based hyperthermic intra-peritoneal chemotherapy for ovarian peritoneal carcinomatosis","volume":"29","author":"Angeles","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2026.03.012_bb0030","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1245\/s10434-022-12661-3","article-title":"Extensive peritonectomy is an independent risk factor for cisplatin HIPEC-induced acute kidney injury","volume":"30","author":"Liesenfeld","year":"2023","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2026.03.012_bb0035","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00595-017-1596-5","article-title":"Risk factors for and the prevention of acute kidney injury after abdominal surgery","volume":"48","author":"An","year":"2018","journal-title":"Surg. Today"},{"key":"10.1016\/j.ygyno.2026.03.012_bb0040","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1245\/s10434-021-10376-5","article-title":"HIPEC-induced acute kidney injury: a retrospective clinical study and preclinical model","volume":"29","author":"Liesenfeld","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2026.03.012_bb0045","article-title":"The addition of sodium thiosulphate to hyperthermic intraperitoneal chemotherapy with cisplatin in ovarian cancer","volume":"37","author":"Glennon","year":"2021","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.ygyno.2026.03.012_bb0050","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1245\/s10434-021-10508-x","article-title":"Sodium thiosulfate reduces acute kidney injury in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with cisplatin: a single-center observational study","volume":"29","author":"Kurreck","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2026.03.012_bb0055","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/02656736.2020.1795277","article-title":"Sodium thiosulfate protects from renal impairement following hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin","volume":"37","author":"Laplace","year":"2020","journal-title":"Int. J. Hyperthermia"},{"key":"10.1016\/j.ygyno.2026.03.012_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.107955","article-title":"Eliminating the need for preoperative intravenous hyperhydration: sodium thiosulfate as nephrotoxicity prevention in HIPEC-treated patients - a retrospective analysis","volume":"50","author":"Vachez","year":"2024","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2026.03.012_bb0065","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1634\/theoncologist.2016-0319","article-title":"A systematic review of strategies to prevent cisplatin-induced nephrotoxicity","volume":"22","author":"Crona","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.ygyno.2026.03.012_bb0070","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin. Pract."},{"key":"10.1016\/j.ygyno.2026.03.012_bb0075","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/967826","article-title":"Pathophysiology of cisplatin-induced acute kidney injury","volume":"2014","author":"Ozkok","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ygyno.2026.03.012_bb0080","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1093\/oncolo\/oyad297","article-title":"Hydration methods for cisplatin containing chemotherapy: a systematic review","volume":"29","author":"Sikking","year":"2024","journal-title":"Oncologist"},{"key":"10.1016\/j.ygyno.2026.03.012_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.804685","article-title":"Protective effect of mannitol on cisplatin-induced nephrotoxicity: a systematic review and Meta-analysis","volume":"11","author":"Li","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ygyno.2026.03.012_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.108622","article-title":"Acute kidney injury after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy - a systematic review","volume":"50","author":"Solanki","year":"2024","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2026.03.012_bb0095","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2215\/CJN.16541221","article-title":"Postoperative acute kidney injury","volume":"17","author":"Boyer","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ygyno.2026.03.012_bb0100","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1213\/ANE.0000000000001323","article-title":"Acute kidney injury after abdominal surgery: incidence, risk factors, and outcome","volume":"122","author":"Long","year":"2016","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ygyno.2026.03.012_bb0105","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jcrc.2016.05.012","article-title":"Postoperative acute kidney injury in high-risk patients undergoing major abdominal surgery","volume":"35","author":"Romagnoli","year":"2016","journal-title":"J. Crit. Care"}],"updated-by":[{"DOI":"10.1016\/j.ygyno.2026.06.004","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000}}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826019323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826019323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:34:52Z","timestamp":1793597692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825826019323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":21,"alternative-id":["S0090825826019323"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.03.012","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating alternative protocols for preventing cisplatin-induced acute kidney injury during hyperthermic intraperitoneal chemotherapy in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}